Program Committee

Adam Aten, MPH, MSc 
Policy Research Associate         
Duke-Margolis Center for Health Policy, Bethesda, MD, USA


Marc Berger, MD       
Consultant and Scientific Advisor; Retired, New York, NY, USA
Gracy Crane, PhD       
Regulatory Policy Lead, Roche, Welwyn, England, UK
William Crown, PhD    
Distinguished Research Scientist, Brandeis University, Waltham, MA, USA


Nancy Dreyer, MPH, PhD    
Chief Scientific Officer Emerita, Dreyer Strategies LLC, Newton, MA, USA


Wim Goettsch, PhD    
Special Advisor HTA, Zorginstituut Nederland, Dieman, Netherlands


Jennifer Graff, PharmD 
Senior Director, Professional Affairs, AMCP, Kensington, MD, USA


Rachele Hendricks Sturrup, DHSc, MSc, MA     
Research Director, RWE, Duke-Margolis Center for Health Policy, Washington, DC, USA


Pall Jonsson, BSc, PhD  
Programme Director - Data, National Institute for Health and Care Excellence, Manchester, England, UK


Christina Mack, MSPH, PhD     
Vice President, Epidemiology, IQVIA, Chapel Hill, NC, USA


Daniel Mullins, PhD    
Professor, University of Maryland Baltimore, Baltimore, MD, USA


Lucinda Orsini, MPH    
Vice President, Value and Outcomes Research, COMPASS Pathways, Skillman, NJ, USA


Anton Pottegård, PhD, DMSc   
Professor, University of Southern Denmark, Odense, Denmark


Sebastian Schneeweiss, ScD, MD        
Professor of Medicine and Epidemiology at Harvard Medical School and Chief of the Division of Pharmacoepidemiology, Department of Medicine, Brigham and Women’s Hospital, Boston, MA, USA


Massoud Toussi, MBA, MSc, PhD, MD  
Global Category Lead, RWE, IQVIA, Courbevoie, France


David Van Brunt, PhD  
Head of Real-World Data Science, Astellas, Libertyville, IL, USA


Shirley Wang, PhD      
Associate Professor, Brigham & Women's Hospital, Harvard Medical School, Boston, MA, USA